Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 255

1.

Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017.

Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Pannaraj PS, Givner LB, Hulten KG.

Pediatrics. 2019 Sep;144(3). pii: e20190567. doi: 10.1542/peds.2019-0567. Epub 2019 Aug 16.

PMID:
31420369
2.

Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial.

Bradley JS, Roilides E, Broadhurst H, Cheng K, Huang LM, MasCasullo V, Newell P, Stone GG, Tawadrous M, Wajsbrot D, Yates K, Gardner A.

Pediatr Infect Dis J. 2019 Sep;38(9):920-928. doi: 10.1097/INF.0000000000002395.

PMID:
31335570
3.

Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial.

Bradley JS, Broadhurst H, Cheng K, Mendez M, Newell P, Prchlik M, Stone GG, Talley AK, Tawadrous M, Wajsbrot D, Yates K, Zuzova A, Gardner A.

Pediatr Infect Dis J. 2019 Aug;38(8):816-824. doi: 10.1097/INF.0000000000002392.

PMID:
31306396
4.

Ceftolozane-Tazobactam Population Pharmacokinetics and Dose Selection for Further Clinical Evaluation in Pediatric Patients with Complicated Urinary Tract or Complicated Intra-abdominal Infections.

Larson KB, Patel YT, Willavize S, Bradley JS, Rhee EG, Caro L, Rizk ML.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02578-18. doi: 10.1128/AAC.02578-18. Print 2019 Jun.

PMID:
30962340
5.

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.

Arrieta AC, Sung L, Bradley JS, Zwaan CM, Gates D, Waskin H, Carmelitano P, Groll AH, Lehrnbecher T, Mangin E, Joshi A, Kartsonis NA, Walsh TJ, Paschke A.

PLoS One. 2019 Mar 26;14(3):e0212837. doi: 10.1371/journal.pone.0212837. eCollection 2019.

6.

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT.

Clin Infect Dis. 2019 Mar 5;68(6):895-902. doi: 10.1093/cid/ciy874. No abstract available.

PMID:
30834445
7.

Community-acquired pneumonia in children: cell-free plasma sequencing for diagnosis and management.

Farnaes L, Wilke J, Ryan Loker K, Bradley JS, Cannavino CR, Hong DK, Pong A, Foley J, Coufal NG.

Diagn Microbiol Infect Dis. 2019 Jun;94(2):188-191. doi: 10.1016/j.diagmicrobio.2018.12.016. Epub 2019 Feb 2.

8.

Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study.

Stass H, Lettieri J, Vanevski KM, Willmann S, James LP, Sullivan JE, Arrieta AC, Bradley JS.

J Clin Pharmacol. 2019 May;59(5):654-667. doi: 10.1002/jcph.1358. Epub 2019 Jan 25.

PMID:
30681729
9.

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT.

Clin Infect Dis. 2019 Mar 5;68(6):e1-e47. doi: 10.1093/cid/ciy866.

10.

Optimizing Antibiotic Drug Therapy in Pediatrics: Current State and Future Needs.

Le J, Bradley JS.

J Clin Pharmacol. 2018 Oct;58 Suppl 10:S108-S122. doi: 10.1002/jcph.1128.

PMID:
30248202
11.

Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection.

Bradley JS, Ang JY, Arrieta AC, Larson KB, Rizk ML, Caro L, Yang S, Yu B, Johnson MG, Rhee EG.

Pediatr Infect Dis J. 2018 Nov;37(11):1130-1136. doi: 10.1097/INF.0000000000002170.

PMID:
30153232
12.

Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents.

Gonzalez D, James LP, Al-Uzri A, Bosheva M, Adler-Shohet FC, Mendley SR, Bradley JS, Espinosa C, Tsonkova E, Moffett K, Marquez L, Simonsen KA, Stoilov S, Boakye-Agyeman F, Jasion T, Hornik CP, Hernandez R, Benjamin DK Jr, Cohen-Wolkowiez M.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00692-18. doi: 10.1128/AAC.00692-18. Print 2018 Aug.

13.

Antiviral treatment of childhood influenza: an update.

Moodley A, Bradley JS, Kimberlin DW.

Curr Opin Pediatr. 2018 Jun;30(3):438-447. doi: 10.1097/MOP.0000000000000618. Review.

PMID:
29745939
14.

Trivalent flu vaccine may provide cross protection of circulating influenza B.

Bradley JS.

BMJ. 2018 Feb 20;360:k725. doi: 10.1136/bmj.k725. No abstract available.

PMID:
29463504
15.

Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia.

Arrieta AC, Bradley JS, Popejoy MW, Bensaci M, Grandhi A, Bokesch P, Glasser C, Du L, Patino H, Kartsonis NA.

Pediatr Infect Dis J. 2018 Sep;37(9):893-900. doi: 10.1097/INF.0000000000001926.

PMID:
29406465
16.

Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage.

Olarte L, Kaplan SL, Barson WJ, Romero JR, Lin PL, Tan TQ, Hoffman JA, Bradley JS, Givner LB, Mason EO, Hultén KG.

Emerg Infect Dis. 2018 Feb;24(2):405. doi: 10.3201/eid2402.170982. No abstract available.

17.

Multimodal Treatment of Rhinocerebral Mucormycosis in a Pediatric Patient With Relapsed Pre-B Acute Lymphoblastic Leukemia.

Dworsky ZD, Bradley JS, Brigger MT, Pong AL, Kuo DJ.

Pediatr Infect Dis J. 2018 Jun;37(6):555-558. doi: 10.1097/INF.0000000000001839.

PMID:
29189615
18.

Low Infection-Related Re-Admission Rates in a Retrospective of 4725 Children with Appendicitis Using a Clinical Pathway in a Tertiary Care Pediatric Center.

Marino NE, Davenport K, Hilfiker M, Langness S, Fairbanks T, Stucky Fisher E, Newbury R, Andrews A, Wells A, Chaparro JD, Bradley JS.

Surg Infect (Larchmt). 2017 Nov/Dec;18(8):894-903. doi: 10.1089/sur.2017.104. Epub 2017 Oct 24.

PMID:
29064344
19.

Intravenous Zanamivir in Hospitalized Patients With Influenza.

Bradley JS, Blumer JL, Romero JR, Michaels MG, Munoz FM, Kimberlin DW, Pahud B, DeBiasi RL, Yamamoto G, Roberts G, Hossain M, Shortino D, Yates PJ, Adams B, Peppercorn A.

Pediatrics. 2017 Nov;140(5). pii: e20162727. doi: 10.1542/peds.2016-2727.

20.

Global shortage of neonatal and paediatric antibiotic trials: rapid review.

Thompson G, Barker CI, Folgori L, Bielicki JA, Bradley JS, Lutsar I, Sharland M.

BMJ Open. 2017 Oct 13;7(10):e016293. doi: 10.1136/bmjopen-2017-016293. Review.

21.

Extensive orf infection in a toddler with associated id reaction.

Haddock ES, Cheng CE, Bradley JS, Hsu CH, Zhao H, Davidson WB, Barrio VR.

Pediatr Dermatol. 2017 Nov;34(6):e337-e340. doi: 10.1111/pde.13259. Epub 2017 Sep 21.

22.

Pharmacokinetics of single-dose ceftaroline fosamil in children with cystic fibrosis.

Le J, Bradley JS, Hingtgen S, Skochko S, Black N, Jones RN, Lim M, Capparelli EV.

Pediatr Pulmonol. 2017 Nov;52(11):1424-1434. doi: 10.1002/ppul.23827. Epub 2017 Sep 14.

PMID:
28910514
23.

Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period.

Le J, Dam Q, Tran T, Nguyen A, Adler-Shohet FC, Kim S, Schmidt K, Lieberman JM, Bradley JS.

Epidemiol Infect. 2017 Sep;145(12):2631-2639. doi: 10.1017/S0950268817001571. Epub 2017 Jul 27.

PMID:
28748772
24.

An Observational Study of Severe Pertussis in 100 Infants ≤120 Days of Age.

Cherry JD, Wendorf K, Bregman B, Lehman D, Nieves D, Bradley JS, Mason WH, Sande-Lopez L, Lopez M, Federman M, Chen T, Blumberg D, Johnston S, Schwenk HT, Weintrub P, Quinn KK, Winter K, Harriman K.

Pediatr Infect Dis J. 2018 Mar;37(3):202-205. doi: 10.1097/INF.0000000000001710.

PMID:
28737623
25.

Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.

Avedissian SN, Bradley E, Zhang D, Bradley JS, Nazer LH, Tran TM, Nguyen A, Le J.

Pediatr Crit Care Med. 2017 Sep;18(9):e388-e394. doi: 10.1097/PCC.0000000000001228.

PMID:
28640009
26.

Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era.

Olarte L, Barson WJ, Bradley JS, Tan TQ, Lin PL, Romero JR, Givner LB, Hoffman JA, Hultén KG, Mason EO, Kaplan SL.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):249-252. doi: 10.1093/jpids/pix034.

PMID:
28510699
27.

Reduced skeletal muscle fiber size following caloric restriction is associated with calpain-mediated proteolysis and attenuation of IGF-1 signaling.

Lu Y, Bradley JS, McCoski SR, Gonzalez JM, Ealy AD, Johnson SE.

Am J Physiol Regul Integr Comp Physiol. 2017 May 1;312(5):R806-R815. doi: 10.1152/ajpregu.00400.2016. Epub 2017 Feb 22.

28.

Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era.

Olarte L, Barson WJ, Barson RM, Romero JR, Bradley JS, Tan TQ, Givner LB, Hoffman JA, Lin PL, Hultén KG, Mason EO, Kaplan SL.

Clin Infect Dis. 2017 Jun 15;64(12):1699-1704. doi: 10.1093/cid/cix115.

PMID:
28199482
29.

Tissue organization alters gene expression in equine induced trophectoderm cells.

Reinholt BM, Bradley JS, Jacobs RD, Ealy AD, Johnson SE.

Gen Comp Endocrinol. 2017 Jun 1;247:174-182. doi: 10.1016/j.ygcen.2017.01.030. Epub 2017 Feb 2.

PMID:
28161437
30.

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.

Gonzalez D, Bradley JS, Blumer J, Yogev R, Watt KM, James LP, Palazzi DL, Bhatt-Mehta V, Sullivan JE, Zhang L, Murphy J, Ussery XT, Puttagunta S, Dunne MW, Cohen-Wolkowiez M.

Pediatr Infect Dis J. 2017 Jul;36(7):645-653. doi: 10.1097/INF.0000000000001538.

31.

Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era.

Olarte L, Lin PL, Barson WJ, Romero JR, Tan TQ, Givner LB, Hoffman JA, Bradley JS, Hultén KG, Mason EO, Kaplan SL.

Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12630. Epub 2016 Dec 28.

PMID:
27862712
32.

Plane of nutrition affects growth rate, organ size and skeletal muscle satellite cell activity in newborn calves.

MacGhee ME, Bradley JS, McCoski SR, Reeg AM, Ealy AD, Johnson SE.

J Anim Physiol Anim Nutr (Berl). 2017 Jun;101(3):475-483. doi: 10.1111/jpn.12568. Epub 2016 Nov 18.

PMID:
27859677
33.

Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States.

Olarte L, Kaplan SL, Barson WJ, Romero JR, Lin PL, Tan TQ, Hoffman JA, Bradley JS, Givner LB, Mason EO, Hultén KG.

J Clin Microbiol. 2017 Mar;55(3):724-734. doi: 10.1128/JCM.01778-16. Epub 2016 Nov 9.

34.

Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia.

Riccobene TA, Khariton T, Knebel W, Das S, Li J, Jandourek A, Carrothers TJ, Bradley JS.

J Clin Pharmacol. 2017 Mar;57(3):345-355. doi: 10.1002/jcph.809. Epub 2016 Sep 27.

PMID:
27510635
35.

Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients.

Bradley JS, Armstrong J, Arrieta A, Bishai R, Das S, Delair S, Edeki T, Holmes WC, Li J, Moffett KS, Mukundan D, Perez N, Romero JR, Speicher D, Sullivan JE, Zhou D.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6252-9. doi: 10.1128/AAC.00862-16. Print 2016 Oct.

36.

Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review.

Folgori L, Bielicki J, Ruiz B, Turner MA, Bradley JS, Benjamin DK Jr, Zaoutis TE, Lutsar I, Giaquinto C, Rossi P, Sharland M.

Lancet Infect Dis. 2016 Sep;16(9):e178-e189. doi: 10.1016/S1473-3099(16)00069-4. Epub 2016 Jun 30. Review.

PMID:
27375212
37.

A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection.

Korczowski B, Antadze T, Giorgobiani M, Stryjewski ME, Jandourek A, Smith A, O'Neal T, Bradley JS.

Pediatr Infect Dis J. 2016 Aug;35(8):e239-47. doi: 10.1097/INF.0000000000001191.

PMID:
27164462
38.

Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure.

Cannavino CR, Mendes RE, Sader HS, Farrell DJ, Critchley IA, Biek D, Le J, Skochko SM, Jones RN, Bradley JS.

Pediatr Infect Dis J. 2016 Jul;35(7):813-5. doi: 10.1097/INF.0000000000001171.

PMID:
27093165
39.

A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone.

Cannavino CR, Nemeth A, Korczowski B, Bradley JS, O'Neal T, Jandourek A, Friedland HD, Kaplan SL.

Pediatr Infect Dis J. 2016 Jul;35(7):752-9. doi: 10.1097/INF.0000000000001159.

PMID:
27093162
40.

A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia.

Blumer JL, Ghonghadze T, Cannavino C, O'Neal T, Jandourek A, Friedland HD, Bradley JS.

Pediatr Infect Dis J. 2016 Jul;35(7):760-6. doi: 10.1097/INF.0000000000001160.

PMID:
27078119
41.

Community Attitudes and Practices of Urban Residents Regarding Predation by Pet Cats on Wildlife: An International Comparison.

Hall CM, Adams NA, Bradley JS, Bryant KA, Davis AA, Dickman CR, Fujita T, Kobayashi S, Lepczyk CA, McBride EA, Pollock KH, Styles IM, van Heezik Y, Wang F, Calver MC.

PLoS One. 2016 Apr 6;11(4):e0151962. doi: 10.1371/journal.pone.0151962. eCollection 2016.

42.

Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents.

Bradley JS, Flanagan SD, Arrieta AC, Jacobs R, Capparelli E, Prokocimer P.

Pediatr Infect Dis J. 2016 Jun;35(6):628-33. doi: 10.1097/INF.0000000000001096.

PMID:
26910588
43.

Population Pharmacokinetic Assessment and Pharmacodynamic Implications of Pediatric Cefepime Dosing for Susceptible-Dose-Dependent Organisms.

Shoji K, Bradley JS, Reed MD, van den Anker JN, Domonoske C, Capparelli EV.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2150-6. doi: 10.1128/AAC.02592-15. Print 2016 Apr.

44.

Selection for divergent body size alters rates of embryonic skeletal muscle formation and muscle gene expression patterns.

Lu Y, Bradley JS, Siegel PB, Yang N, Johnson SE.

Dev Growth Differ. 2015 Dec;57(9):614-24. doi: 10.1111/dgd.12250. Epub 2015 Dec 10.

PMID:
26660844
45.

Osteoarticular Infections in Children.

Arnold JC, Bradley JS.

Infect Dis Clin North Am. 2015 Sep;29(3):557-74. doi: 10.1016/j.idc.2015.05.012. Review.

PMID:
26311358
46.

Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia.

Cannavino CR, Castaneda-Ruiz B, Redman R, Go O, Cirillo I, Barauskas V, Senatorova G, Emeryk A, Bradley JS.

Pediatr Infect Dis J. 2015 Nov;34(11):1264-7. doi: 10.1097/INF.0000000000000859.

PMID:
26226440
47.

Bayesian Estimation of Vancomycin Pharmacokinetics in Obese Children: Matched Case-Control Study.

Le J, Capparelli EV, Wahid U, Wu YS, Romanowski GL, Tran TM, Nguyen A, Bradley JS.

Clin Ther. 2015 Jun 1;37(6):1340-51. doi: 10.1016/j.clinthera.2015.05.006. Epub 2015 May 29.

48.

Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age.

Cirillo I, Vaccaro N, Castaneda-Ruiz B, Redman R, Cossey V, Bradley JS, Allegaert K.

Antimicrob Agents Chemother. 2015 Aug;59(8):4742-9. doi: 10.1128/AAC.00485-15. Epub 2015 May 26.

49.

Creep-feeding to stimulate metabolic imprinting in nursing beef heifers: impacts on heifer growth, reproductive and physiological variables.

Reis MM, Cooke RF, Cappellozza BI, Marques RS, Guarnieri Filho TA, Rodrigues MC, Bradley JS, Mueller CJ, Keisler DH, Johnson SE, Bohnert DW.

Animal. 2015 Sep;9(9):1500-8. doi: 10.1017/S1751731115000828. Epub 2015 May 20.

PMID:
25990965
50.

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children.

Olarte L, Barson WJ, Barson RM, Lin PL, Romero JR, Tan TQ, Givner LB, Bradley JS, Hoffman JA, Hultén KG, Mason EO, Kaplan SL.

Clin Infect Dis. 2015 Sep 1;61(5):767-75. doi: 10.1093/cid/civ368. Epub 2015 May 13.

PMID:
25972022

Supplemental Content

Loading ...
Support Center